维普中文期刊产品整合服务
22篇 您的检索式:作者名="CHEN Fengxi"
    题名 作者 年代 出处 被引量
1Blocking the recruitment of naive CD4+ T cells reverses immunosuppression in breast cancer显示文摘渗入肿瘤的 Tregs 的起源,肿瘤免疫力的抑制的批评调停人,是不清楚的。这里,,我们证明在人的乳癌的渗入肿瘤的天真的 CD4 + T 房间和 Tregs 有重叠 TCR 全部剧目几乎别与传播 Tregs 重叠,建议 intratumoral Tregs 主要在 situ 而非从招募的 Tregs 从天真的 T 房间发展。而且,许多天真的 CD4 + T 房间和 Tregs 密切被相关,两个显示的穷人为乳癌病人的预后。天真的 CD4 + T 房间与许多生产 CCL18 巨噬细胞成比例遵守肿瘤片。而且,采纳地转移的人的天真的 CD4 + T 房间以一种 CCL18 依赖的方式渗入人的乳癌 orthotopic 异种皮移植。在在人性化的鼠标的人的乳癌异种皮移植,由将 PITPNM3 的表达式击倒堵住天真的 CD4 + T 房间的招募进肿瘤, CCL18 受体,显著地减少 intratumoral Tregs 并且禁止肿瘤前进。这些调查结果建议那个乳房渗入肿瘤的 Tregs 从在 situ 区分进 Tregs 的传播天真的 CD4 + T 房间的趋化性产生。由防碍 CCL18 的 PITPNM3 识别禁止天真的 CD4 + T 房间招募进肿瘤可以是为 anticancer 免疫疗法的吸引人的策略。Shicheng Su Jianyou Liao Jiang Liu Di Huang Chonghua He Fei Chen LinBing Yang Wei Wu Jianing Chen Ling Lin Yunjie Zeng Nengtai Ouyang Xiuying Cui Herui Yao Fengxi Su Jian-dong Huang Judy Lieberman Qiang Liu Erwei Song 2017Cell Research2017,27,4:19
2ERK1/2 mediates lung adenocarcinoma cell proliferation and autophagy induced by apelin-13显示文摘这研究的目的是在房间增长和肺腺癌的 autophagy 调查 apelin 的角色。在肺腺癌的 APJ 的在表示上被 immunohistochemistry 检测,当在肺癌症病人的血浆 apelin 水平被连接酶的 immunosorbent 试金测量时。我们的调查结果表明 apelin-13 显著地增加了 ERK1/2 的 phosphorylation, cyclin D1 的表示,联系微导管的蛋白质 1 轻链 3A/B (LC3A/B ) ,和 beclin1,并且证实 apelin-13 支持了 A549 房间增长并且经由 ERK1/2 发信号导致了 A549 房间 autophagy。而且,人的肺腺癌房间线 A549 的表面和光滑、光滑的 apelin-13 原因房间表面上有毛孔是在原子力量下面观察了显微镜学。这些结果建议 ERK1/2 发信号小径调停 apelin-13-induced 肺腺癌房间增长和 autophagy。在我们的试验性的条件下面,与 3-methyladenine 联系的 autophagy 不涉及房间增长。Li Yang Tao Su Deguan Lv FengXie Wei Liu Jiangang Cao Irshad Ali Sheikh Xuping Qin Lanfang Li Linxi Chen 2014Acta Biochimica et Biophysica Sinica2014,46,2:15
3Comparison of breast-conserving surgery and mastectomy in early breast cancer using observational data revisited:a propensity score-matched analysis显示文摘Recent observational studies showed that breast-conserving surgery(BCS) resulted in superior survival compared to mastectomy in breast cancer patients. This study compared the clinical outcomes of BCS and mastectomy using propensity score(PS)matching analysis, which had advantages over conventional methods in reducing bias. Nonmetastatic breast cancer patients who underwent BCS and mastectomy were matched 1:1 based on their PS. We used the Kaplan-Meier method and Cox-regression model to estimate the treatment effects. A total of 2,866 patients with a median follow-up time of 67 months were included in the original study population. Although the mastectomy cohort(N=1,219) had more advanced disease compared to the BCS cohort(N=1,647), LRFS was similar between the two groups(93.8% vs. 92.4%, P>0.05). BCS(vs. mastectomy) was associated with improved DFS(73.8% vs. 58.7%, P<0.01) and CSS(91% vs. 78.2%, P<0.01) in the original population. In the PS-matched population(N=1,668), clinicopathological features were equally distributed between the two cohorts. BCS(vs. mastectomy) was not associated with improved DFS(70.7% vs. 66.9%, P>0.05) or CSS(87.5% vs. 84.9%, P>0.05). We found that PS methods reduce bias when estimating treatment effects using observational data. BCS and mastectomy show equivalent outcomes in nonmetastatic breast cancer patients.Kai Chen Zihao Pan Liling Zhu Tingting Hu Min Peng Weijuan Jia Fengxi Su Shunrong Li Erwei Song 2018Science China(Life Sciences)2018,61,12:12
4Introduction of a multicenter online database for non-metastatic breast cancer in China显示文摘Dear Editor,Breast cancer is now the most frequently diagnosed cancer and is the fifth leading cause of cancer-related death in Chinese women. Therefore, the burden of breast cancer in China is gradually increasing. According to figures released by the Chinese Cancer Center in 2018, the number of newly diagnostic breast cancer is about 278,900 cases, accounting for 16.51%of all women who were diagnosed with the first primary malignant tumors;and 66,000 cases of breast cancer died in 2014 (Chen et al., 2016).Yaping Yang Jieqiong Liu Min Peng Fengxi Su Xiaoming Xie Zhenzhen Liu Jundong Wu Wei Wei Dongxian Zhou Weiwen Li Ailing Zhang Guosen Su Weixiong Yang Jishang Chen Dekui Ma Yongguang Cai Kai Chen Liling Zhu Qiang Liu Erwei Song 2020Science China(Life Sciences)2020,63,9:4
5Induction of fibroblasts to neurons through adenoviral gene delivery显示文摘Fengxi Meng Siye Chen Qinglong Miao Kechun Zhou Qicheng Lao Xiaohui Zhang Wenyi Guo Jianwei Jiao 2012Cell Research2012,22,2:4
6In pursuit of a flawless aphrodite:paving the way to scarless oncoplastic breast surgery显示文摘Introduction Breast cancer is the most commonly diagnosed malig-nancy in women worldwide[1,2]and in the twentieth century,mastectomy was the primary surgical treatment for breast cancer patients.Advances in breast-conserving surgery(BCS)propelled a change in treatment rational from“maximum tolerable”to“minimum effective”ther-apy.Oncoplastic breast surgery aims to restore the shape of the breast and has been widely adopted since the past decade.Although the cosmetic outcome has been sig-nificantly improved,the scar remaining on the surgeried breast skin is still a major pitfall that urges urgent consid-eration.In this editorial,we review a series of techniques that can be incorporated in oncoplastic breast surgery to minimize scarring,signifying the beginning of an era for scarless oncoplastic surgery.Liling Zhu Shunrong Li Luyuan Tan Xiaolan Zhang Jiannan Wu Fengxi Su Kai Chen Erwei Song 2019Cancer Communications2019,39,1:4
7A Positive Feedback Loop between Mesenchymal-like Cancer Cells and Macrophages Is Essential to Breast Cancer Metastasis显示文摘Shicheng Su Qiang Liu Jingqi Chen Jianing Chen Fei Chen Chonghua He Di Huang Wei Wu Ling Lin Wei Huang Jin Zhang Xiuying Cui Fang Zheng Haiyan Li Herui Yao Fengxi Su Erwei Song 2014Cancer Cell2014,,5:3
8Prepara- tion and characterization of coral-like nanostructured o-Mn2O3 catalyst for catalytic combustion of methane显示文摘Kanaparthi Ramesh Luwei Chen Fengxi Chen 2007Catalysis Communication2007,8,:1
9Semi-continuous emulsion copolymerization of butyl methacrylate with polymerizable anionic surfactants 显示文摘Xiao-Jun Xu Fengxi Chen 2004Polymer2004,45,14:1
10Modified emulsifier-free emulsion polymerization of butyl methacrylate ionic or/and nonionic comoners显示文摘Xiaojun Xu Fengxi Chen 2004J Appl Polym Sci2004,92,:1
11Synthesis and characterization of Mn3O4 and Mn2O3 nanocrystals on SBA-15: Novel combustion catalysts at low reaction temperatures 显示文摘Yi-Fan Han Fengxi Chen Zi-Yi Zhong 2006Catalysis Communications2006,,7:1
12Synthesis of MCM-48 Using Mixed Cationic-Anionic Surfactants as Tem- plates显示文摘Chen Fengxi Huang Liming Li Quanzhi 1997Chem Mater1997,9,12:1
13CCL18 from Tumor-Associated Macrophages Promotes Breast Cancer Metastasis via PITPNM3显示文摘Jingqi Chen Yandan Yao Chang Gong Fengyan Yu Shicheng Su Jianing Chen Bodu Liu Hui Deng Fengsong Wang Ling Lin Herui Yao Fengxi Su Karen S. Anderson Qiang Liu Mark E. Ewen Xuebiao Yao Erwei Song 2011Cancer Cell2011,,4:1
14Effect of Hydro- thermal Conditions on the Synthesis of Siliceous MCM-48 in Mixed Cationic-Anionic Surfactants Systems 显示文摘Chen Fengxi Yan Xuewu Li Quanzhi 1998Stud SurfSci Catal1998,117,:1
15Mixed Cationic- Anionic Templating Route to A1-MCM-48 显示文摘Chen Fengxi Song Fubing Li Quanzhi 1999Microporous MesoporousMater1999,29,3:1
16Face recognition based on a novel linear discriminant criterion显示文摘Fengxi Song David Zhang Qinglong Chen 2007Pattern Anal Applic2007,10,3:1
17Controlled synthesis,characterization,and catalytic properties of Mn2O3and Mn3O4nanoparticles supported on mesoporous silica SBA-15显示文摘HAN Yifan CHEN Fengxi ZHONG Ziyi 2006Journal of Physical Chemistry:B2006,110,24:1
18Controlled syn- thesis,chara- cterization, and catalytic properties of Mn2O3 and Mn3O4 nanoparticales supported on mesoporous silica SBA-15显示文摘Han Yifan Chen Fengxi Zhong Ziyi 2006J PhyChemB2006,110,24:1
19Synthesis and characterization of MnaO4 and Mn203 nanocrystals on SBA- 15: Novel combustion catalysts at low reaction temperatures 显示文摘Han Yifan Chen Fengxi Zhong Ziyi 2006CatalCommun2006,7,10:1
20Semi-continuous emulsion copolymerization of butyl methacrylate with ploymerizable anionic surfactants显示文摘XUA Xiaojun CHEN Fengxi 2004Polymer2004,45,3:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费